Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and efficacy of a cardiovascular polypill in people at high and very high risk without a previous cardiovascular event: the international VULCANO randomised clinical trial.
Mostaza JM, Suárez-Fernández C, Cosín-Sales J, Gómez-Huelgas R, Brotons C, Araujo FP, Borrayo G, Ruiz E; VULCANO investigators. Mostaza JM, et al. BMC Cardiovasc Disord. 2022 Dec 22;22(1):560. doi: 10.1186/s12872-022-03013-w. BMC Cardiovasc Disord. 2022. PMID: 36550424 Free PMC article. Clinical Trial.
Effect of atorvastatin and bezafibrate on plasma levels of C-reactive protein in combined (mixed) hyperlipidemia.
Gómez-Gerique JA, Ros E, Oliván J, Mostaza JM, Vilardell M, Pintó X, Civeira F, Hernández A, da Silva PM, Rodriguez-Botaro A, Zambón D, Lima J, Díaz C, Aristegui R, Sol JM, Chaves J, Hernández G; ATOMIX Investigators. Gómez-Gerique JA, et al. Among authors: mostaza jm. Atherosclerosis. 2002 Jun;162(2):245-51. doi: 10.1016/s0021-9150(01)00708-0. Atherosclerosis. 2002. PMID: 11996943 Clinical Trial.
[Cardiovascular risk assessment].
Suárez C, Alvarez-Sala L, Mostaza J, Asenjo C. Suárez C, et al. Med Clin (Barc). 2007 Oct 20;129(14):534-41. doi: 10.1157/13111428. Med Clin (Barc). 2007. PMID: 17983533 Review. Spanish. No abstract available.
Atorvastatin versus Bezafibrate in Mixed Hyperlipidaemia : Randomised Clinical Trial of Efficacy and Safety (the ATOMIX Study).
Ros E, Oliván J, Mostaza JM, Vilardell M, Pintó X, Civeira F, Hernández A, Marqués da Silva P, Rodriguez-Botaro A, Zambón D, Lima J, Gómez-Gerique JA, Díaz C, Arístegui R, Sol JM, Hernández G. Ros E, et al. Among authors: mostaza jm. Clin Drug Investig. 2003;23(3):153-65. doi: 10.2165/00044011-200323030-00002. Clin Drug Investig. 2003. PMID: 23340922
Unanswered clinical questions in the management of cardiometabolic risk in the elderly: a statement of the Spanish Society of Internal Medicine.
Gómez-Huelgas R, Giner-Galvañ V, Mostaza JM, Cuende JI, de Miguel-Yanes JM, Rovira E, Sánchez-Fuentes D, Suárez Fernández C, Román Sánchez P; SEMI Working Group. Gómez-Huelgas R, et al. Among authors: mostaza jm. BMC Cardiovasc Disord. 2014 Dec 18;14:193. doi: 10.1186/1471-2261-14-193. BMC Cardiovasc Disord. 2014. PMID: 25519433 Free PMC article.
[Consensus document of the Spanish Society of Arteriosclerosis on indications of inhibitors of PCSK9].
Masana L, Ascaso JF, Civeira F, Pedro-Botet J, Valdivielso P, Guijarro C, Mostaza J, López Miranda J, Pintó X; en nombre de la Sociedad Española de Arteriosclerosis. Masana L, et al. Clin Investig Arterioscler. 2016 May-Jun;28(3):164-5. doi: 10.1016/j.arteri.2016.02.001. Epub 2016 Mar 11. Clin Investig Arterioscler. 2016. PMID: 26976748 Spanish. No abstract available.
Toward a new clinical classification of patients with familial hypercholesterolemia: One perspective from Spain.
Masana L, Ibarretxe D, Rodríguez-Borjabad C, Plana N, Valdivielso P, Pedro-Botet J, Civeira F, López-Miranda J, Guijarro C, Mostaza J, Pintó X; Expert group from the Spanish Arteriosclerosis Society. Masana L, et al. Atherosclerosis. 2019 Aug;287:89-92. doi: 10.1016/j.atherosclerosis.2019.06.905. Epub 2019 Jun 20. Atherosclerosis. 2019. PMID: 31238171 Free article. Review.
Overall Mortality and LDL Cholesterol Reduction in Secondary Prevention Trials of Cardiovascular Disease.
Pedro-Botet J, López-Miranda J, Badimón L, Civeira F, Guijarro C, Millán J, Mostaza JM, Pintó X, Valdivielso P, Masana L; Expert group from the Spanish Arteriosclerosis Society. Pedro-Botet J, et al. Among authors: mostaza jm. Am J Cardiovasc Drugs. 2020 Aug;20(4):325-332. doi: 10.1007/s40256-019-00376-y. Am J Cardiovasc Drugs. 2020. PMID: 31650523 Review.
Consensus on lipoprotein(a) of the Spanish Society of Arteriosclerosis. Literature review and recommendations for clinical practice.
Delgado-Lista J, Mostaza JM, Arrobas-Velilla T, Blanco-Vaca F, Masana L, Pedro-Botet J, Perez-Martinez P, Civeira F, Cuende-Melero JI, Gomez-Barrado JJ, Lahoz C, Pintó X, Suarez-Tembra M, Lopez-Miranda J, Guijarro C. Delgado-Lista J, et al. Among authors: mostaza jm. Clin Investig Arterioscler. 2024 Apr 9:S0214-9168(24)00023-8. doi: 10.1016/j.arteri.2024.03.002. Online ahead of print. Clin Investig Arterioscler. 2024. PMID: 38599943 English, Spanish.
152 results